| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 |
| Phrase | Consultant | Town | Special Interests |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, teenage and young adult oncology, rare gynaecological tumours, complex chemotherapy for brain tumours, sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical Oncology | *Consultant(s)* | *Towns* | Medical Oncology, sarcoma, germ cell tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological cancer, tumour targeting, gastrointestinal cancer, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal oncology, lung cancer, cancer of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, testicular cancer, upper gastrointestinal tumours, melanoma, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, neuroendocrine tumours |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, endocrine cancer, hepatobiliary tumours, early phase clinical trials |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, skin cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, upper gastrointestinal cancers |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, early and advanced breast cancer, endocrine therapy of breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, liver cancer, oesophageal cancer, neuroendocrine tumours, pancreatic cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, genito-urinary cancer, hepatopancreatobiliary cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, acute oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, mesothelioma, ovarian cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, melanoma, renal cell carcinoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, genito-urinary oncology, translational oncology, early drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, BRCA positive ovarian cancer, mesothelioma, thoracic malignancies, gynaecological malignancies |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological malignancies, breast cancer, lung cancer, palliative medicine |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma, breast cancer, teenage and young adult oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, renal cancer, lung cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, thoracic oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, angiogenesis, drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, pharmacology and drug development |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, lymphoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, endocrine resistance in breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, cancer of unknown primary |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, lower gastrointestinal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, sarcoma, soft tissue sarcoma, bone sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, breast oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology, rare cancers, head and neck cancers, sarcoma |
| Medical oncology | *Consultant(s)* | *Towns* | Medical oncology |
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 |
